Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 24381495)

1.

Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes.

Lee JS, Cheong HS, Kim LH, Kim JO, Seo DW, Kim YH, Chung MW, Han SY, Shin HD.

Korean J Physiol Pharmacol. 2013 Dec;17(6):479-84. doi: 10.4196/kjpp.2013.17.6.479. Epub 2013 Dec 16.

2.

Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.

Wang L, Aikemu A, Yibulayin A, Du S, Geng T, Wang B, Zhang Y, Jin T, Yang J.

BMC Genet. 2015 Jun 20;16(1):66. doi: 10.1186/s12863-015-0232-x.

3.

Pharmacogenomic assessment of Mexican and Peruvian populations.

Marsh S, King CR, Van Booven DJ, Revollo JY, Gilman RH, McLeod HL.

Pharmacogenomics. 2015 Apr;16(5):441-8. doi: 10.2217/pgs.15.10.

PMID:
25916516
4.

Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.

Claudio-Campos K, Duconge J, Cadilla CL, Ruaño G.

Drug Metabol Personal Ther. 2015 Jun 1;30(2):87-105. doi: 10.1515/dmdi-2014-0023.

5.

Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia.

Novillo A, Romero-Lorca A, Gaibar M, Bahri R, Harich N, Sánchez-Cuenca D, Esteban E, Fernández-Santander A.

Int J Biol Markers. 2015 Feb 24;30(1):e148-51. doi: 10.5301/jbm.5000118.

PMID:
25385241
6.

High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme.

Apellániz-Ruiz M, Inglada-Pérez L, Naranjo ME, Sánchez L, Mancikova V, Currás-Freixes M, de Cubas AA, Comino-Méndez I, Triki S, Rebai A, Rasool M, Moya G, Grazina M, Opocher G, Cascón A, Taboada-Echalar P, Ingelman-Sundberg M, Carracedo A, Robledo M, Llerena A, Rodríguez-Antona C.

Pharmacogenomics J. 2015 Jun;15(3):288-92. doi: 10.1038/tpj.2014.67. Epub 2014 Nov 4.

PMID:
25348618
7.

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.

Han JH, Lee YS, Kim HJ, Lee SY, Myung SC.

Asian J Androl. 2015 Mar-Apr;17(2):285-91. doi: 10.4103/1008-682X.133320.

8.

In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia.

Gézsi A, Lautner-Csorba O, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Hegyi M, Csordás K, Kovács G, Szalai C.

Pharmacogenomics J. 2015 Jun;15(3):241-7. doi: 10.1038/tpj.2014.60. Epub 2014 Sep 30.

PMID:
25266680
9.

CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort.

Kitzmiller JP, Luzum JA, Baldassarre D, Krauss RM, Medina MW.

Pharmacogenet Genomics. 2014 Oct;24(10):486-91. doi: 10.1097/FPC.0000000000000079.

10.

Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.

Yi S, An H, Lee H, Lee S, Ieiri I, Lee Y, Cho JY, Hirota T, Fukae M, Yoshida K, Nagatsuka S, Kimura M, Irie S, Sugiyama Y, Shin DW, Lim KS, Chung JY, Yu KS, Jang IJ.

Pharmacogenet Genomics. 2014 Oct;24(10):477-85. doi: 10.1097/FPC.0000000000000075.

PMID:
25029633
11.

Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations.

Kim JH, Cheong HS, Park BL, Kim LH, Shin HJ, Na HS, Chung MW, Shin HD.

Arch Pharm Res. 2015 Jan;38(1):115-28. doi: 10.1007/s12272-014-0348-y. Epub 2014 Mar 24.

PMID:
24988984
12.

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.

Kohlrausch FB, Carracedo Á, Hutz MH.

Mol Biol Rep. 2014 Mar;41(3):1453-60. doi: 10.1007/s11033-013-2990-8. Epub 2014 Jan 18.

PMID:
24443221
13.

Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in living donor liver transplantation.

Chiu KW, Nakano T, Chen KD, Hsu LW, Lai CY, Chiu HC, Huang CY, Cheng YF, Goto S, Chen CL.

World J Hepatol. 2013 Nov 27;5(11):642-8. doi: 10.4254/wjh.v5.i11.642.

14.

Screening of dihydropyrimidine dehydrogenase genetic variants by direct sequencing in different ethnic groups.

Shin JG, Cheong HS, Kim JY, Kim LH, Han CS, Kim JO, Kim HD, Kim YH, Chung MW, Han SY, Shin HD.

J Korean Med Sci. 2013 Aug;28(8):1129-33. doi: 10.3346/jkms.2013.28.8.1129. Epub 2013 Jul 31.

15.

Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.

Bains RK, Kovacevic M, Plaster CA, Tarekegn A, Bekele E, Bradman NN, Thomas MG.

BMC Genet. 2013 May 3;14:34. doi: 10.1186/1471-2156-14-34.

16.

Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients.

Willrich MA, Rodrigues AC, Cerda A, Genvigir FD, Arazi SS, Dorea EL, Bernik MM, Bertolami MC, Faludi A, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RD.

Clin Chim Acta. 2013 Jun 5;421:157-63. doi: 10.1016/j.cca.2013.03.007. Epub 2013 Mar 15.

17.

Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.

Zuo XC, Ng CM, Barrett JS, Luo AJ, Zhang BK, Deng CH, Xi LY, Cheng K, Ming YZ, Yang GP, Pei Q, Zhu LJ, Yuan H, Liao HQ, Ding JJ, Wu D, Zhou YN, Jing NN, Huang ZJ.

Pharmacogenet Genomics. 2013 May;23(5):251-61. doi: 10.1097/FPC.0b013e32835fcbb6.

PMID:
23459029
18.
19.

Characterization of the genetic variation present in CYP3A4 in three South African populations.

Drögemöller B, Plummer M, Korkie L, Agenbag G, Dunaiski A, Niehaus D, Koen L, Gebhardt S, Schneider N, Olckers A, Wright G, Warnich L.

Front Genet. 2013 Feb 18;4:17. doi: 10.3389/fgene.2013.00017. eCollection 2013.

20.

Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.

Staehli Hodel EM, Csajka C, Ariey F, Guidi M, Kabanywanyi AM, Duong S, Decosterd LA, Olliaro P, Beck HP, Genton B.

Antimicrob Agents Chemother. 2013 Feb;57(2):950-8. doi: 10.1128/AAC.01700-12. Epub 2012 Dec 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk